Search results
www .actavis .com. Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Aug 2, 2016 · Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic acquisition brings together two leading generics businesses with complementary strengths, R&D capabilities, product pipelines ...
Actavis (now Allergan) | 46,698 followers on LinkedIn. We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk ...
Feb 18, 2014 · DUBLIN & NEW YORK--(BUSINESS WIRE)--Actavis plc (NYSE:ACT) and Forest Laboratories, Inc. (NYSE:FRX) today announced that they have entered into a definitive agreement under which Actavis will ...
Nov 23, 2014 · Actavis. shares for each share of . Allergan. common stock. Based on the closing price of . Actavis. shares on . November 14, 2014, the transaction is valued at approximately . $66 billion, or . $219. per . Allergan. share. The combination will create one of the top 10 global pharmaceutical companies by sales revenue, with combined annual pro ...
Feb 18, 2014 · Actavis will pay $26.04 plus 0.3306 share per Forest Labs share. That's equal to $92.65 as of Tuesday's close, following Actavis' 5% gain to 201.47. Forest Labs shot up 27.5% to 91.04.
